Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.
Filed
Email me when HB 642 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 642. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
HB 642 proposes legislation concerning the prior‑authorization process for prescription‑drug benefits used to treat neurodegenerative conditions. It would apply to patients, health‑care providers and insurers that handle these medications. The measure aims to modify how such benefits are authorized, though the filing does not detail specific changes.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 642
3 free questions a day, no accountSponsors
- Venton Jones (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 642 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 642 freeOr ask your AI assistant about HB 642 directly:
Add to Claude, ChatGPT or Cursor